Der p 1‐specific regulatory T‐cell response during house dust mite allergen immunotherapy
T Boonpiyathad, M Sokolowska, H Morita, B Rückert… - Allergy, 2019 - Wiley Online Library
Background Allergen‐specific immunotherapy (AIT) is the only available treatment for
allergic diseases that can induce specific immune tolerance to allergens. The key …
allergic diseases that can induce specific immune tolerance to allergens. The key …
Der p 1‐specific regulatory T‐cell response during house dust mite allergen immunotherapy.
T Boonpiyathad, M Sokolowska, H Morita… - Allergy, 2019 - search.ebscohost.com
Background: Allergen‐specific immunotherapy (AIT) is the only available treatment for
allergic diseases that can induce specific immune tolerance to allergens. The key …
allergic diseases that can induce specific immune tolerance to allergens. The key …
Der p 1-specific regulatory T-cell response during house dust mite allergen immunotherapy.
T Boonpiyathad, M Sokolowska, H Morita, B Rückert… - Allergy, 2019 - europepmc.org
Background Allergen-specific immunotherapy (AIT) is the only available treatment for
allergic diseases that can induce specific immune tolerance to allergens. The key …
allergic diseases that can induce specific immune tolerance to allergens. The key …
Der p 1-specific regulatory T-cell response during house dust mite allergen immunotherapy
T Boonpiyathad, M Sokolowska, H Morita, B Rückert… - Allergy, 2019 - zora.uzh.ch
BACKGROUND: Allergen-specific immunotherapy (AIT) is the only available treatment for
allergic diseases that can induce specific immune tolerance to allergens. The key …
allergic diseases that can induce specific immune tolerance to allergens. The key …
Der p 1‐specific regulatory T‐cell response during house dust mite allergen immunotherapy
T Boonpiyathad, M Sokolowska, H Morita, B Rückert… - Allergy, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Allergen‐specific immunotherapy (< jats: styled-content style=" fixed-case"> AIT</jats: styled …
Allergen‐specific immunotherapy (< jats: styled-content style=" fixed-case"> AIT</jats: styled …
Der p 1-specific regulatory T-cell response during house dust mite allergen immunotherapy.
T Boonpiyathad, M Sokolowska, H Morita, B Rückert… - Allergy, 2019 - folia.unifr.ch
METHODS We studied 25 allergic rhinitis patients undergoing subcutaneous house dust
mite-specific immunotherapy. Peripheral blood mononuclear cells were studied before and …
mite-specific immunotherapy. Peripheral blood mononuclear cells were studied before and …
Der p 1-specific regulatory T-cell response during house dust mite allergen immunotherapy
T Boonpiyathad, M Sokolowska, H Morita… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Allergen-specific immunotherapy (AIT) is the only available treatment for
allergic diseases that can induce specific immune tolerance to allergens. The key …
allergic diseases that can induce specific immune tolerance to allergens. The key …
Der p 1-specific regulatory T-cell response during house dust mite allergen immunotherapy.
T Boonpiyathad, M Sokolowska, H Morita, B Rückert… - Allergy, 2019 - sonar.ch
METHODS We studied 25 allergic rhinitis patients undergoing subcutaneous house dust
mite-specific immunotherapy. Peripheral blood mononuclear cells were studied before and …
mite-specific immunotherapy. Peripheral blood mononuclear cells were studied before and …
Der p 1-specific regulatory T-cell response during house dust mite allergen immunotherapy.
T Boonpiyathad, M Sokolowska, H Morita, B Rückert… - 2019 - cabidigitallibrary.org
Background: Allergen-specific immunotherapy (AIT) is the only available treatment for
allergic diseases that can induce specific immune tolerance to allergens. The key …
allergic diseases that can induce specific immune tolerance to allergens. The key …